The effects of fexofenadine on eosinophilia and systemic anaphylaxis in mice infected with Trichinella spiralis

International Immunopharmacology

Volumn 4, Issue 3, 2004, Pages 367-375

  Watanabe, Naohiro ^a   Matsuda, Emiko ^b   Masuda, Akiko ^b   Nariai, Koichi ^a   Shibasaki, Toshiaki ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Anaphylaxis; Eosinophil; Fexofenadine; Mice

Indexed keywords

EOTAXIN; FEXOFENADINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 5; PARASITE ANTIGEN;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EOSINOPHILIA; MALE; MAST CELL; MOUSE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECTUM TEMPERATURE; SINGLE DRUG DOSE; TRANSGENIC MOUSE; TRICHINELLA SPIRALIS;

ANAPHYLAXIS; ANIMALS; ANTIGENS, HELMINTH; CHEMOKINES, CC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; EOSINOPHILIA; HISTAMINE H1 ANTAGONISTS; INTERLEUKIN-5; INTESTINE, SMALL; MALE; MAST CELLS; MICE; SPECIES SPECIFICITY; TERFENADINE; TRICHINELLA SPIRALIS; TRICHINOSIS;

EID: 1642266549     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.10.009     Document Type: Article

References (23)

1. Kay A.B. Allergy and allergic diseases. N. Engl. J. Med. 344:2001;30-37.
2. Kay A.B. Allergy and allergic diseases. N. Engl. J. Med. 44:2001;109-113.
3. 1 receptors. J. Immunol. 166:2001;4083-4091.
4. Abdelaziz M.M., Devalia J.L., Khair O.A., Bayram H., Prior A.J.et al. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J. Allergy Clin. Immunol. 101:1998;410-420.
5. Hindmarch I., Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin. Exp. Allergy. 29:1999;133-142.
6. Nicholson A.N., Stone B.M., Turner C., Mills S.L. Antihistamines and aircrew: usefulness of fexofenadine. Aviat. Space Environ. Med. 71:2000;2-6.
7. Finkelman F.D., Pearce E.J., Urban J.F., Sher A. Regulation and biological function of helminth-induced cytokine responses. Immunol. Today. 12:1991;A62-A66.
8. v mice and their increase by bone marrow transplantation. Blood. 52:1978;447-452.
9. Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J.et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9:1997;461-466.
10. Watanabe N., Katakura K., Kobayashi A., Okumura K., Ovary Z. Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis. Proc. Natl. Acad. Sci. U. S. A. 85:1988;4460-4462.
11. Bruschi F., Pozio E., Watanabe N., Gomez-Morales M.A., Ito M.et al. Anaphylactic response to parasite antigens: IgE and IgG1 independently induce death in Trichinella-infected mice. Int. Arch. Allergy Immunol. 119:1999;291-296.
12. Hirano T., Miyajima H., Kitagawa H., Watanabe N., Azuma M.et al. Studies on murine IgE with monoclonal antibodies: I. Characterization of rat monoclonal anti-IgE antibodies and the use of these antibodies for determination of serum IgE levels and for anaphylactic reactions. Int. Arch. Allergy Appl. Immunol. 85:1988;47-54.
13. Ujike A., Ishikawa Y., Ono M., Yuasa T., Yoshino T.et al. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J. Exp. Med. 189:1999;1573-1579.
14. Dombrowicz D., Flamad V., Miyajima I., Ravetch J.V., Galli S.J., Kinet J.-P. Absence of FcεRIα chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcεRI and FcγRIII for limiting amounts of FcR β and γ chain. J. Clin. Invest. 99:1997;915-925.
15. Holgate S.T., Riche W.R., Church M.K. The role of the eosinophil in asthma. Am. Rev. Respir. Dis. 143:1991;S66-S70.
16. Galli S.J. New concepts about the mast cell. N. Engl. J. Med. 328:1993;257-265.
17. Coffman R.L., Seymour B.W.P., Hudak S., Jackson J., Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 245:1989;308-310.
18. Tachimoto H., Ebisawa M., Kimata M., Mori K., Akasawa A.et al. Activated human mast cells release factors supporting the survival of eosinophils in vitro. Int. Arch. Allergy Immunol. 113:1997;393-394.
19. Jose P.T., Griffiths-Johnson D.A., Collins P.D., Walsh D.T., Moqbel R.et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a Guinea pig model of allergic airway inflammation. J. Exp. Med. 179:1994;881-887.
20. Garcia-Zepeda E.A., Rothenberg M.E., Ownbey R.T., Celestin J., Lusler A.D. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:1996;449-456.
21. Paolieri F., Battifora M., Riccio A.M., Bertolini C., Cutolo M.et al. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann. Allergy Asthma Immunol. 81(6):1998;601-607.
22. Gelfand E.W., Cui Z.H., Takeda K., Kanehiro A., Joetham A. Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. J. Allergy Clin. Immunol. 110:2002;85-95.
23. Flood-Page P.T., Menzies-Gow A.N., Kay A.B., Robinson D.S. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med. 167(2):2003;199-204.